Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 106Head & Neck 21Gynecologic 20Genitourinary 19Endocrine 17Thoracic 16Tumor-Agnostic 7Other solid neoplasm 7Dermatologic 7CNS 7Breast 6NET 5Sarcoma 4

Conditions

Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Osteosarcoma 1Bone Neoplasms 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × lenvatinib × Sarcoma × Clear all
NCT07619950 2026-06-02

EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Yonsei University

Phase 2 Not yet recruiting
94 enrolled
Sarcoma

Bone Neoplasms

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn
Sarcoma

Sarcoma, Kaposi

NCT07359053 2026-01-22

MAGNATE-S

Shanghai 6th People's Hospital

Phase 2 Recruiting
46 enrolled
Sarcoma

Sarcoma

NCT04154189 2024-07-22

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Eisai Inc.

Phase 2 Completed
81 enrolled 22 charts
Sarcoma

Recurrence, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡